Dr. Karan Pankaj Desai, MD

Dr. Desai practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Desai's NPI, 1538555909, was assigned on April 12, 2015. Dr. Desai graduated from Albany Medical College of Union University in 2015. Dr. Desai holds Virginia license 0101280724.

Dr. Desai's primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Desai's primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Desai is also affiliated with Inova Fairfax Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Desai to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Desai practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Desai's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Desai is licensed in Virginia.

CMS data shows 3,002 Medicare services from Dr. Desai across 24 procedure codes in 2024, for 1,620 Medicare patients. Medicare paid $142,830 for them.

CMS counts 1,620 Medicare patients who saw Dr. Desai in 2024. The largest group is 75 to 84, with 629 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Desai's median patient age at 59, with 50% women.

In 2024, Dr. Desai wrote 889 Medicare Part D claims for 266 patients. 83% of them were for generic drugs. CMS names the drug for 761 of them, across 24 drugs with 11 or more claims each, at $149,891 in total drug cost. In 2023, CMS named 974 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Desai for performance year 2024, reported as part of a group. Dr. Desai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Desai as offering telehealth.

CMS Open Payments shows 42 general payments to Dr. Desai from 21 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $190.

Dr. Desai graduated from Albany Medical College of Union University in 2015.